X4 Pharmaceuticals EV - Enterprise Value | XFOR

Annual EV - Enterprise Value X4 Pharmaceuticals

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
66 M	96.9 M	4.71 M	15.1 M	24 M	128 M	4.45 M	46.3 M	22.9 M	60.7 M	43.8 M	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
128 M	4.45 M	46.7 M

EV - Enterprise Value of other stocks in the Biotechnology industry

Issuer	EV - Enterprise Value	Price	% 24h	Market Cap	Country
Precision BioSciences DTIL	16 M	$ 6.31	0.16 %	$ 80.9 M	USA
Dyadic International DYAI	35.6 M	$ 0.45	0.31 %	$ 16.3 M	USA
Editas Medicine EDIT	218 M	$ 2.79	6.49 %	$ 248 M	USA
Edesa Biotech EDSA	497 K	$ 3.91	1.3 %	$ 22.2 M	USA
Enlivex Therapeutics Ltd. ENLV	434 M	$ 0.36	0.36 %	$ 16.5 M	Israel
Enanta Pharmaceuticals ENTA	184 M	$ 12.6	0.93 %	$ 269 K	USA
Entera Bio Ltd. ENTX	85.4 M	$ 2.62	0.69 %	$ 121 M	Israel
Equillium EQ	91.1 M	$ 1.45	2.84 %	$ 83.1 M	USA
Eton Pharmaceuticals ETON	599 M	$ 55.62	0.47 %	$ 1.5 B	USA
Evogene Ltd. EVGN	1.49 M	$ 0.4	3.54 %	$ 3.15 M	Israel
Exelixis EXEL	11.9 B	$ 58.85	0.79 %	$ 16 B	USA
EyePoint Pharmaceuticals EYPT	-42.8 M	$ 3.15	0.62 %	$ 231 K	USA
Fate Therapeutics FATE	140 M	$ 2.43	4.74 %	$ 289 M	USA
Fortress Biotech FBIO	122 M	$ 2.09	2.96 %	$ 58.3 M	USA
Fennec Pharmaceuticals FENC	167 M	$ 10.62	4.12 %	$ 303 M	USA
Fulcrum Therapeutics FULC	359 M	$ 3.71	0.54 %	$ 235 M	USA
Merus N.V. MRUS	2.82 B	-	-	$ 5.78 B	Niderland
Galectin Therapeutics GALT	306 M	$ 3.73	3.72 %	$ 238 M	USA
Geron Corporation GERN	1.33 B	$ 1.21	0.83 %	$ 807 M	USA
Gilead Sciences GILD	176 B	$ 144.63	0.85 %	$ 180 B	USA
Greenwich LifeSciences GLSI	386 M	$ 16.91	0.77 %	$ 229 M	USA
Genmab A/S GMAB	1.41 B	$ 38.48	10.73 %	$ 2.49 B	Danmark
Genprex GNPX	-3.98 M	$ 2.72	3.42 %	$ 2.54 M	USA
Gossamer Bio GOSS	365 M	$ 10.65	0.37 %	$ 2.43 B	USA
GeoVax Labs GOVX	658 K	$ 0.32	1.31 %	$ 307 K	USA
Grifols, S.A. GRFS	16.3 B	$ 7.41	1.37 %	$ 5.04 B	Spain
GlaxoSmithKline plc GSK	258 B	$ 46.55	0.93 %	$ 189 B	Britain
GT Biopharma GTBP	-2.9 M	$ 6.16	0.98 %	$ 34 M	USA
Halozyme Therapeutics HALO	12 B	$ 108.31	2.73 %	$ 13 B	USA
Hutchison China MediTech Limited HCM	12.4 B	$ 14.31	0.77 %	$ 12.3 B	China
Harmony Biosciences Holdings HRMY	1.26 B	$ 39.92	0.71 %	$ 2.3 B	USA
Heron Therapeutics HRTX	411 M	$ 0.37	6.44 %	$ 61.7 M	USA
iBio IBIO	98.5 M	$ 1.12	0.89 %	$ 117 M	USA
ImmuCell Corporation ICCC	69.7 M	$ 9.75	1.56 %	$ 88 M	USA
IDEAYA Biosciences IDYA	2.7 B	$ 38.06	1.87 %	$ 3.37 B	USA
InflaRx N.V. IFRX	60.9 M	$ 1.68	0.58 %	$ 113 M	Germany
Immutep Limited IMMP	2.92 B	$ 4.27	0.46 %	$ 6.22 B	Australia
Immunome IMNM	1.28 B	$ 21.17	1.29 %	$ 1.85 B	USA
Immuron Limited IMRN	230 M	$ 1.07	0.46 %	$ 247 M	Australia
Immatics N.V. IMTX	389 M	$ 7.73	1.84 %	$ 946 M	Germany
Immunic IMUX	160 M	$ 8.07	1.38 %	$ 1.26 B	USA
Immunovant IMVT	5.69 B	$ 33.25	0.18 %	$ 6.07 B	USA
Innate Pharma S.A. IPHA	98.2 M	$ 1.58	1.28 %	$ 142 M	France
Incyte Corporation INCY	18.2 B	$ 114.13	0.06 %	$ 22.3 B	USA
InMed Pharmaceuticals INM	5.21 M	$ 1.33	0.01 %	$ 5.54 M	Canada
INmune Bio INMB	12.3 M	$ 1.94	0.52 %	$ 48 M	USA
Inovio Pharmaceuticals INO	104 M	$ 1.15	2.05 %	$ 53.9 M	USA
Insmed Incorporated INSM	32.6 B	$ 103.83	2.33 %	$ 20.7 B	USA
Innoviva INVA	1.07 B	$ 20.64	0.68 %	$ 1.39 B	USA
Iovance Biotherapeutics IOVA	52.9 M	$ 14.15	0.63 %	$ 5.06 M	USA